Yingjun Chang

32PUBLICATIONS
39CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTransplantation immunologyHaematologyHaematological tumoursRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 11, 2026
Targeting SMC3 deacetylation synergizes with XPO1 inhibition to reprogram the epigenetic landscape and suppress NPM1-mutated acute myeloid leukemia.

|Apr 06, 2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse.

Xiao-Tong Chen, Ze-Chang Shi, Yu Wang

|Apr 02, 2026
Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study.

Wenxuan Huo, Chuanhe Jiang, Congxiao Zhang

|Mar 21, 2026
Is sex chromosome loss a predictive marker for outcome after sex-mismatched allogeneic hematopoietic stem cell transplantation?

Lu Gao, Na Li, Lin Feng

|Mar 12, 2026
Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale Cohort.

Yijing Zhao, Ting Zhao, Feifei Tang

|Aug 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective study.

Si-Qi Li, Lan-Ping Xu, Yu Wang

Pageof 6

Frequent Collaborators

14 joint publications

Yu Wang

14 joint publications

Xiaojun Huang

12 joint publications

Xiaohui Zhang

10 joint publications

Xiaodong Mo